25 August 2009
Tunisian pharmaceutical laboratory "Saiph" successfully developed the first generic anti-viral drug to treat H1N1 swine flu, Arabic weekly Assabah Al Osbouii quoted Tunisian health officials as saying on Monday (August 24th).

The announcement comes amid World Health Organization (WHO) warnings of a second wave of the swine flu pandemic. The drug will be sold under the name "Siflu".

© Magharebia.com 2009